tumour cells

send to a friend share this

Champalimaud Research Symposium 2022 - CRSy22

Champalimaud Centre for the Unknown (CCU) in Lisbon, Portugal

 

19 - 21 October, 2022

 

See more informations here: https://symposium.fchampalimaud.science/

 

Reduced fees for ASPIC members.

Champalimaud Research Symposium 2022 - CRSy22

Champalimaud Centre for the Unknown (CCU) in Lisbon, Portugal

 

19 - 21 October, 2022

 

See more informations here: https://symposium.fchampalimaud.science/

 

Reduced fees for ASPIC members.

Computational model of the first steps in bladder cancer development

The mechanical properties of cells and extracellular environment, in particular their stiffness and adhesion capacity, are important in the early stages of bladder cancer initiation. A computational model, developed at the University of Coimbra, describes the different layers of the urothelium and allows to study which characteristics are most relevant to the invasive capacity of neighboring tissues by tumor cells. This work provides useful indications for the development of alternative therapeutic strategies. 

 

Authors and Affiliations:

Oncology at the Limits

Royal College of Physicians, London, United Kingdom

 

15 - 17 March, 2017

 

See more informations here: https://www.atthelimits.org/oncology/oatl-2017/introduction/

Oncology at the Limits

Royal College of Physicians, London, United Kingdom

 

15 - 17 March, 2017

 

See more informations here: https://www.atthelimits.org/oncology/oatl-2017/introduction/

Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells

Extracellular vesicles (EVs) are released from all cells, being not only relevant for physiological processes but also for pathological processes such as cancer. Different types of EVs, including exosomes and microvesicles, have different intracellular origin and biogenesis (exosomes have endosomal origin and smaller sizes while microvesicles have a plasma membrane origin and bigger sizes). EVs may carry different types of molecules from the donor cells, such as proteins and microRNAs.

CRUK Cambridge Institute Annual International Symposium - Unanswered Questions: Tumours at Cellular Resolution

CRUK Cambridge Institute, United Kingdom

 

4 - 5 March, 2016

 

See more informations here: http://www.cruk.cam.ac.uk/symposium/home

CRUK Cambridge Institute Annual International Symposium - Unanswered Questions: Tumours at Cellular Resolution

CRUK Cambridge Institute, United Kingdom

 

4 - 5 March, 2016

 

See more informations here: http://www.cruk.cam.ac.uk/symposium/home

Innovative combination of techniques reveals the anticancer effect of human defensin on tumor cells

Portuguese researchers unravelled the anticancer activity of the human neutrophil peptide-1, HNP-1, on prostate adenocarcinoma and leukemia cells. This study, recently published in Biochimica et Biophysica Acta – Molecular Cell Research Journal, combines spectroscopic techniques and atomic force microscopy (AFM) for elucidating the peptide’s mode of action and determining potential factors contributing for the peptide’s selective activity toward prostate tumor cells.